The Vaper Expo 2017 Birmingham NEC

Superior Vapour
It's that time of the year again, and the crew at Superior Vapour are well up for this years expo and heres why.
We have a huge stand this year and on our stands we will have some powerhouse brands with us.

FIND US ON STAND A205

We have Purge Mods along side us, bringing you the best hardware in the game at the moment and they might even have there squonkers with them! ^^

Hollywood vape labs: Premium canadian liquids, with over 30 flavours, there setting the juice game alight.

RemixBar: New innovative way to short fill 100ml bottles stocking only the finest american juice brands.

Monster Freeze: IF you like your cool, chilled fruity flavours, these juices are creeping it real. There to " ghoul " for school.... Ok enough.

JWell: Well established ecig supplier from france who have an eye for style and quality.

Directions and tickets can be found on Vaper Expo's website.
See you there! 

Read more →

VapeJam 2017

Superior Vapour
We're going to VapeJam @ ExCeL, London, are you?
We are really excited for VapeJam this year, we will  be bringing lot's speciality hardware with us from some of your favourite brands!
Vape Jam UK is returning to ExCeL London for its third instalment, in April 2017. After two successful years Vape Jam UK remains the leading electronic cigarette and vape related trade show in the United Kingdom. The three day event will consist of one full trade day on the 7th and two consumer days on the 8th and 9th of April.
You can find us on stand J30. 
 More info can be found on VapeJams website.
 
 

Read more →

What is TPD and what effect will it have?

Superior Vapour

When the Government introduced its Tobacco and Related Regulations in May 2016, the tobacco industry was given a six month period in which to comply with the new legislation. These regulations have been introduced in the UK as a result of the European Tobacco Products Directive (TPD), with which all member states of the European Union must comply (we’ll look at the consequences of the UK leaving the EU later on).

The TPD encompasses all ‘tobacco related products’, including cigarettes, rolling tobacco and chewing tobacco, as well as vaping products. The stated focus of the Directive is to discourage young people from smoking and to ensure that all EU citizens are made aware of the harm smoking can have on their health and well-being.

Controversially, Article 20 of the TPD relates to vaping, e-liquids and vaping related products, even though these are arguably not tobacco related products.

That six-month transition period came to an end in November 2016 so we think it’s timely to look at what effect TPD will have on vaping in the UK had and what the future holds for the industry.

What does Article 20 of the TPD entail?

The rules laid out in Article 20 cover everything connected to the manufacture and importation of e-cigarettes and vapours and every aspect of the supply and retail chain.

Because some e-cigarettes contain nicotine, the Directive has set a maximum permitted concentration of 20 milligrams per millilitre, which is less than the current level of 24 milligrams per millilitre. At the same time, the maximum capacity of a tank is restricted to 2 millilitres, down from the 5 millilitres which is the most common size currently on sale. Refill containers will now have a maximum capacity of 10 millilitres.

E-cigarettes must also be tamper proof and child-resistant and must be constructed in such a way as to prevent spillage when refilled.

All e-cigarette packaging and vaping kits are required to carry mandatory health warnings and state that they contain nicotine. They must also include a leaflet, if the information is not on the packaging itself, containing advice on the adverse effects of smoking, addictiveness and the product’s toxicity. There cannot be any promotional elements on the packets. Also required on the packet or in the leaflet are instructions about keeping the product out of reach of children, explaining which groups are at risk if the devices are used by them, and that the products should not be used by non-smokers.

The promotion of e-cigarettes and cross-border advertising is also prohibited. This legislation is likely to have an impact on British exporters as the trade in these products involves what some consider to be draconian red tape.

What happened in the six-month transition period?

From the moment the TPD was introduced in May, all producers of new and modified e-cigarettes, vaping and pod vape kits and refill merchandise, had to notify the Medicines and Healthcare products Regulatory Agency (MHRA).

The notification has to include a description of the ingredients contained in the products; toxicological data; the inclusion of any possible addictive compounds; details about emissions of the product; the voltage/wattage of a battery and whether it is adjustable; and whether the wick can be changed. The products must then be thoroughly tested before approval is granted.

The list of notifications is formidable and you could be excused for thinking that the authorities are making life as difficult as possible to deter all but the most robust manufacturers from going through the procedure. However, since the sector is still growing rapidly and has become very profitable, the additional bureaucracy is unlikely to slow the market or deter manufacturers.

There are also fees which have to be paid when submitting these notifications, which currently stand at £150, in addition to an annual fee of £60 for each product. In Belgium, regulators are asking for a fee of 4,000 Euros to test any new products, so UK manufacturers are actually getting off lightly.

The onus is on the manufacturer to supply the information; not the retailer. However, anyone selling the products should ensure that they comply with the TPD regulations. If they are found to be selling products which do not fall within TPD guidelines, the stock will be confiscated and they could lose their license to sell tobacco merchandise of any kind.

Products which did not comply with the new regulations could still be supplied during the six-month period and retailers have a further six months in which to sell them. Any of the unregulated products still on their shelves after May 2017 must be disposed of. Meanwhile, all products supplied after November 2016 are required to comply with the TPD protocols.

The EU Directive also obliges member states to monitor the sector to determine if there is any evidence which suggests that the use of e-cigarettes or vapours leads to an increase in the consumption of tobacco, or nicotine addiction, especially among non-smokers or young people. The findings will be collated and reviewed by the EU Commission in five years.

Home Made E-Juice

One of the major rules being brought about by the TPD will involve limitations placed on tank sizes (2ml), e-liquid bottle sizes (10ml) and nicotine concentrations (20mg). Flavour concentrates as well as PG and VG concentrations will not be affected, nor will zero nicotine e-liquids.

Vaping suppliers and shops can still purchase high nicotine concentrates wholesale as long as it is being used for commercial purposes (whatever these are). In effect this means vapers will be limited to 20mg nicotine concentrate in 10ml bottles (2%). For DIY e-juicers it will still be possible to mix nicotine shots to create low nicotine concoctions in larger bottles. Flavour bottles can also be used to add flavour to flavourless nicotine to create concentrations of anything between 12mg and 18mg. The homemade e-liquid is far from dead in other words.

Implications on Importing and Exporting

The TPD has huge implications on the importing of e-liquids into the UK, as rules state that all e-liquids have to be made with EU or USA pharma grade nicotine, meaning many Chinese manufacturers may be cut out of the market. E-liquids will also need to undergo testing, which could take up to 6 months to approve before a licence to sell is granted. This is likely to put off many US manufacturers as well, although there is evidence some of the larger ones will invest in compliance to continue having access to the lucrative EU market.

The testing requirements will include emissions testing to identify any harmful components in the vapour produced. Nicotine dosage will test for consistency of nicotine delivery and toxicology tests will look at the e-liquid itself to make sure no harmful components are found.

Under the TPD the onus for testing and submissions will be placed on the manufacturer and the importer. The costs associated with this means that many smaller retailers will be put off from importing products from outside the EU.

What will happen post-Brexit?

The TPD has been implemented with varying degrees of fervour across the member states of the EU, with the UK allegedly taking a more relaxed approach than some of its counterparts in Europe. The lower fees charged for the statutory notification are but one example.

One of the rallying cries for those who advocated leaving the European Union was for Britain to regain control of the laws it made rather than being dictated to by Brussels. Prime Minister Theresa May has said that all current legislation will initially be maintained but will be subsequently reviewed to ascertain whether any change is required.

By the time any Brexit deal is reached and Britain leaves the European Union, all products on sale will be complying with the TPD. There is a general consensus that the laws governing e-cigarettes are unlikely to be altered once Britain has finally left the European Union. It would be virtually impossible for a government of any political persuasion to renege on the packaging and health warnings. More to the point, any alteration in the laws could affect or even derail trade deals with the EU and so this is likely to take precedence over any minor bugbears with Article 20 of the TPD.

Read more →

Royal College of Physicians Endorse Vaping

Superior Vapour
Royal College of Physicians Endorse Vaping
The Royal College of Physicians (RCP) is a professional British organisation with a global reputation. The RCP takes a lead in the development of clinicians, the NHS and takes positions on certain things through the dissemination of reports and studies. The 95% report from Public Health England was a massive goal, giving vaping the lead in the debating cup final. The RCP’s “Nicotine Without Smoke” report puts the harm reduction argument 2-0 up in injury time.

The report stretches to almost 200 pages and goes into great depth on all aspect relating to tobacco-control policy and electronic cigarettes. It covers everything from the science behind nicotine’s absorption and trends through to harm reduction and ethics. Here, we present an overview of the document and some of the comments it has drawn today. POTV will cover aspects of this report, and any fallout, in further depth over the coming week.


While the Public Health England report was attacked, albeit clutching at straws, for some purported link to Big Tobacco, this RCP study has a majority of contributors free from any external interests – and those who did declare some are mostly the result of pharmaceutical funding for discrete projects or speeches.
The report points out the obvious, that smoking is the biggest avoidable cause of death and disability, and social inequality in health, in the UK. The dangers posed by smoking, it says, will result in a cost to society as a result of individuals who are smoking today.
It advocates continuing a vigorous pursuit of conventional tobacco control policies to encourage more smokers to quit smoking, but adds the caveat that quitting smoking is very difficult. The RCP warn that, as it currently stands, most adults who smoke today will continue to smoke for many years – because, repeating the old adage, people smoke because they are addicted to nicotine (but are harmed by the smoke).


The RCP propose that supplying nicotine in a form that contains no smoke prevents most of the harm from smoking and this has traditionally been done through a medical route. The use of these traditional nicotine replacement products (NRT) are most effective, they note, when used in conjunction with the consultation services provided by regional quit programs.
Notably, the report highlights, is that NRT becomes far less successful when used independently by smokers trying to quit without the support of a quit counsellor. The same, they recognize, can’t be said for electronic cigarettes. These have been marketed as consumer products and are proved to be far more effective than NRT products.
And this brings us to the point of whether the contributors believe vaping to be efficacious: does it work? Notably, ecigs tend to be used without quit support and so it carries huge weight when the RCP state: “[they] appear to be effective when used by smokers as an aid to quitting smoking.”
Of course, it’s not all positive – but the report is honest. It draws out the salient point that e-Cigarettes are not made to medicines standards. Although manufacturers may make mention of pharmaceutical grade nicotine, the report mentions that ecigs “are probably more hazardous than NRT.” This caveat is tempered by reference to the Public Health England figure: “the hazard to health arising from long-term vapour inhalation from the e-cigarettes available today is unlikely to exceed 5% of the harm from smoking tobacco.”


When the report logs: “technological developments and improved production standards could reduce the long-term hazard of e-cigarettes”, it raises the spectre of the Tobacco Products Directive’s probably impact. Consumer demand for better products that deliver nicotine and flavour more effectively has driven the continual development of atomisers and mods. If the RCP stand behind their statement about technological development, and the government welcomes the report, then the TPD becomes untenable - its prescriptive nature will stamp out innovation.
Those who are ideologically or financially driven to object to vaping cling to three key criticisms of electronic cigarettes. We see this emanating from California (and Stanton Glantz in particular) all of the time, spouted by Martin McKee at home and was the cornerstone of Labour’s failed attempt to restrict ecig use in Wales. Their fear agenda, drip-fed to the media on a frequent basis and used as an argument for legislation, consists of three key aspects:
Normalisation - That vaping in public will somehow make smoking appear normal and thereby encourage people to adopt cigarettes again.
Gateway – That vaping will encourage ‘never smoked’ ecig users to progress onto traditional cigarettes and become locked into a life of smoking.
Temporary abstinence – That vaping doesn’t lead to long term quitting from smoking
The RCP report addresses these objections in a short, sharp rebuttal: “To date, there is no evidence that any of these processes is occurring to any significant degree in the UK.”


Standing firm, the RCP report states that all of the current evidence supports the notion that electronic cigarettes are being used (almost exclusively) by ex-smokers or by smokers looking to quit. The data showing a continual decline in smoking rates quashes any suggestion of normalisation or a gateway effect. Likewise, the longitudinal studies carried out by Professor West suggest, along with comparable data, that vaping works as a quit tool.
“There is a need,” the report says, “for regulation to reduce direct and indirect adverse effects of e-cigarette use, but this regulation should not be allowed significantly to inhibit the development and use of harm-reduction products by smokers.” It’s a cry for light touch regulation, far lighter than that proposed by the Tobacco Products Directive. It’s a clarion call for the adoption of common sense in the treatment of electronic cigarettes that places health (not dogma and zealotry) at the heart of decision-making.


The RCP advocate “a balanced approach” to any regulatory strategy, be it an attempt to reintroduce measures in Wales or the implementation of the Tobacco Products Directive; an approach that ensures product safety but doesn’t discourage smokers from making the switch from traditional tobacco. Moreover, the RCP raise the fears that ill-considered regulations pose the real risk of having a negative impact on tobacco control targets.
But what of the danger that tobacco companies are now trying to shoehorn their way into the marketplace? Those who speak out against vaping frequently make mention of ecigs using the Big Tobacco playbook in order to grow sales volumes. With the historical baggage this industry brings with it, it is not surprising that people get worried. The report says: “The tobacco industry has become involved in the e-cigarette market and can be expected to try to exploit these products to market tobacco cigarettes, and to undermine wider tobacco control work. However, in the interests of public health it is important to promote the use of e-cigarettes, NRT and other non-tobacco nicotine products as widely as possible as a substitute for smoking in the UK.”


The stance taken supports the notion that regulatory focus should be on the products and benefits they offer rather than fixating on previous products produced by a manufacturer as the opportunity for public health is too great to be held back.
Prof John Britton told the BBC: “The public need to be reassured this is not a new nicotine epidemic in the making. E-cigarettes have very little downside and a lot of potential benefit.”
Also, in an interview with SKY, Britton added: “The growing use of electronic cigarettes as a substitute for tobacco smoking has been a topic of great controversy, with much speculation over their potential risks and benefits. This report lays to rest almost all of the concerns over these products … Smokers should be reassured that these products can help them quit all tobacco use forever.”
The BBC also reports a Department of Health spokesperson saying: “We want to see a wide range of good quality e-cigarettes on the market including licensed products whose safety, quality and effectiveness are independently assured.”
Cancer Research UK’s Alison Cox said: “E-cigarettes have real promise in helping to reduce the huge death toll from tobacco. [The RCP’s report is] an accurate summary of the latest scientific evidence on e-cigarettes. Tobacco kills more than 100,000 people in the UK every year, we should grasp every opportunity to encourage as many people as possible to stop smoking for good.”
Jane Dacre, RCP’s president, said to The Guardian: “with careful management and proportionate regulation, harm reduction provides an opportunity to improve the lives of millions of people. It is an opportunity that, with care, we should take.”
Linda Bauld told Reuters: “The ideal is for people to use nothing, but when the alternative is smoking, people should be encouraged to use nicotine delivered in a cleaner form than in deadly cigarettes. This is what tobacco harm reduction is - it reduces the harm from tobacco while recognising that some people will still use nicotine in other safer forms.”
Deborah Arnott, ASH's chief executive, commented: “Electronic cigarette vapour does not contain smoke, which is why vaping is much less harmful.”
Duncan Selbie, chief executive at Public Health England, told the Mail: “The evidence is clear; vaping is much less harmful to health than smoking, and this report further highlights the important role of e-cigarettes in reducing the deadly harms smoking causes. E-cigarettes are the most popular quitting aid in England and local stop smoking services are the most effective route to giving up, we encourage smokers to combine these, giving them an extremely good chance of quitting smoking successfully.”
Dr Mike Knapton, Associate Medical Director at the British Heart Foundation, added: “E-cigarettes are new devices commonly used by smokers that deliver nicotine without tobacco, and are an effective way of reducing the harm caused. We welcome this report which says that e-cigarettes can be an effective aid to potentially reduce harm from smoking and lower the risk of death and disability. There are 2.6 million e-cigarette users in the UK, and many smokers are using them to help quit. Although more research is needed to establish the long term safety of e-cigarettes, they are likely to cause significantly less harm to your health than smoking tobacco.”
The Royal College of Physicians’ report is, without doubt, a stunningly comprehensive document. It lays bare the lies behind those who advocate a tough approach to the control of vaping and vapers while presenting hard facts for legislators to embrace. It would be fair to say that it, in conjunction with the Public Health England report, places the UK squarely at the vanguard of harm reduction. If there is any sense residing in Parliament, politicians ought to take on board its recommendations and pull the Tobacco Products Directive forthwith before it has a crushing impact on the UK’s small-to-medium electronic cigarette businesses.
Cornelius Drake • 2 days ago
3 years smoke free as of April 26th, all due to ecigs, and I smoked 40 a day starting at age 13 (I'm now 46). Yes, you do need to be aware of people around you, but I find ecig users are better at that than smokers of analog cigarettes. And the financial benefits are amazing, I have not spent over £10,000 on fags, vaping costs me less than 50p a day.

Read more →